Auburn, AL, United States of America

Christopher Weikart

This inventor holds 35 USPTO granted patents and 26 published patent applications, plus 7 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Packaging. Top assignees: Sio2 Medical Products, Inc., Formycon Ag, Klinge Biopharma Gmbh. Active years: 2016-2026.

USPTO Granted Patents = 35 

% Patents Active = 94.3

 

 

Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 212(Granted Patents)


Location History:

  • Aubrn, AL (US) (2021)
  • Auburn, AL (US) (2016 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Packaging
PECVD Coatings
Antistatic Coatings
Low Oxygen Transmission Rate
Blood Collection Tube
Coating Process
Pre-Filled Packages
Polymer Vials
Lubricity Coating
Trilayer Coated
VEGF-Antagonist Formulation
Water Barrier Coatings
35 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christopher Weikart

Introduction: Christopher Weikart, a talented inventor based in Auburn, AL, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Christopher Weikart holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: With a successful career spanning over two decades, Christopher Weikart has worked on numerous projects that have revolutionized industries such as robotics, artificial intelligence, and renewable energy.

Collaborations: Throughout his career, Christopher Weikart has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life and make a positive impact on society.

Conclusion: Christopher Weikart's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…